Margie Gierbolini-Flores, MD
NPI 1033703558ActiveIndividual· General Practice· Coamo, PR
General Practice (MD) in Coamo, Puerto Rico, licensed in PR, with an NPI issued in February 2021. Enrolled in Medicare as practitioner - general practice. Revance Therapeutics, Inc. was the largest of 3 companies reporting payments in 2025, $235.17 in all, mostly food and beverage.
Overview
| NPI | 1033703558 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Feb 24, 2021 |
| Last updated in NPPES | Dec 1, 2025 |
| Certified by provider | Dec 1, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| General Practice Primary | 208D00000X | 24039 | PR |
| Physician Assistant | 363A00000X | 481 | PR |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - General Practice (PR) |
|---|
Industry payments (Open Payments)
- 2025$235.17 · 3 payments from 3 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Revance Therapeutics, Inc. | $140.71 | 1 |
| Glaxosmithkline, LLC. | $51.30 | 1 |
| Genzyme Corporation | $43.16 | 1 |
What the 2025 payments were for
- Food and Beverage$235.17 · 3 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other General Practice providers in Coamo
- 1942427406
- 1578422051
- 1851098537
- 1316976673
- 1801129044
- 1205860723
- 1952953598
- 1043223506
- 1316061542
- 1942980776
- 1235169764
- 1639848625